openPR Logo
Press release

Pet Wearable Market Advancing to reach US$2.5 bn by 2024 at a 12.0% CAGR

02-20-2017 11:02 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Pet Wearable Market Advancing to reach US$2.5 bn by 2024 at a 12.0%

Over the last couple of years, the advent of wearable technology and the ever-growing awareness about pet health, fitness, and safety have resulted in the emergence of pet wearables.

The pet wearable market is presently in its nascent stage and holds significant potential in the ensuing years. Transparency Market Research projects that the spending on pet wearables is likely to surpass that on pet food by 2017.

The global pet wearables market is estimated to be valued at US$1.0 bn by the end of 2016 and is expected to reach US$2.5 bn by 2024 at a 12.0% CAGR therein.

Availability of Advanced Substitutes Threatening Uptake of Identification and Tracking Devices for Pets

In terms of application, the pet wearable market is classified into identification and tracking, facilitation, safety, and security, behaviour monitoring and control, and medical diagnosis and treatment.

Request A Sample Of This Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12701

So far, majority of the demand in the pet wearables market has been generated by the identification and tracking segment.

However, the adoption rate of identification and tracking devices for pets and farm animals is projected to witness a marginal decline during the forecast period mainly due to the availability of substitute products offering similar as well as more advanced and sophisticated features.

Increasing awareness about pet health and fitness among owners, especially in North America and Europe, is expected to fuel the demand for devices providing medical diagnosis.

The medical diagnosis and treatment segment, in combination with the facilitation, safety, and security segment, is expected to account for over a quarter of the pet wearables market by 2024.

About TMR

TMR is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact TMR

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:sales@transparencymarketresearch.com
Website:http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pet Wearable Market Advancing to reach US$2.5 bn by 2024 at a 12.0% CAGR here

News-ID: 443496 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for US$2

Pulse Protein Market to Cross US$ 2 Bn by 2030
Pulse-based protein is linked with many benefits such as lower risk of stroke, cancer, and death from heart disease. Pulse protein also has essential amino acids, as compared to animal protein. Animal protein contains a high amount of saturated fat and dietary cholesterol, which increases heart diseases. Pulse proteins are healthy and delicious meat-free food, ideal for vegetarians and personal wellbeing. The global pulse protein market has witnessed substantial growth
N-Methyl-2-Pyrrolidone Market worth US$ 2 Billion by 2027
N-Methyl-2-Pyrrolidone Market: Key Highlights The N-methyl-2-pyrrolidone (NMP) market was valued at ~US$ 1.1 Bn in 2018, and is anticipated to expand at a CAGR of ~6.0% from 2019 to 2027. The global N-methyl-2-pyrrolidone market is driven by the rise in the demand for N-methyl-2-pyrrolidone from the electronics industry. In terms of value, the N-methyl-2-pyrrolidone market in Asia Pacific is expected to expand at a CAGR of ~8% during the forecast period. China is
N-Methyl-2-Pyrrolidone in Cosmetics worth US$ 2 Billion by 2027
N-Methyl-2-Pyrrolidone Market Holds Multichannel Revenue Opportunities The sales of consumer electronics are showing no signs of slowing down, implying that, manufacturers of electronic devices are investing toward the development of smart-sized products with better functionalities, which manages to attract the attention of consumers. Read report Overview- https://www.transparencymarketresearch.com/n-methyl-2-pyrrolidone-nmpo-market.html Investments made in the consumer electronics market, are, in turn, creating opportunities for the N-methyl-2-pyrrolidone market, given the rising demand for lithium batteries. According to stats published
Blockchain Certification Company Lands US $2 Million Investment
Blockchain is growing, the crypto markets are booming but a serious problem which has now started hurting the whole industry is the involvement of a limited number of people who are currently running the show. More than blockchain literacy, we have developers, traders and investors who are driven by misinformation as there is no set standard in the industry to follow. The whole blockchain is based on open source code and
2-Methylresorcinol Market will reach 83 million US$ in 2023
New report published by Global Info Research which offers insights on the global 2-Methylresorcinol market. 2-Methylresorcinol is a slightly yellow crystalline powder. In cosmetics and personal care products, both Resorcinol and 2-Methylresorcinol are typically used in the formulation of hair dyes and colors. Resorcinol is also used in other hair and skin care products. Click
Liquid Biopsy Market Worth US$ 2 Billion by 2022
New York, April 24: Market Research Engine has published a new report titled as “Liquid Biopsy Market By Type of Cancer Analysis (Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Liver Cancer); By Product and services Analysis (Instruments, Services and Software, Reagents); By Circulation Biomarkers Analysis (Circulating Tumor Cells (CTCs), Extracellular Vesicles (EVs), Circulating Tumor DNA (ctDNA)); By End User Analysis (academic & Research Centers, Reference Laboratories, Hospital and Physician